News

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...
Unique reproducibility effort in Brazil focuses on common methods rather than a single field ― and prompts call for reform.
The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...
Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...
A federal judge in Manhattan is about to wave the green starting flag on a fraud trial mixing NASCAR, a former hedge funder, and a Nvidia-backed tech stock that proved to be a come-from-behind winner.
Ursula von der Leyen warns of escalating trade tensions with the US under Donald Trump, potentially imposing levies on tech giants like ... if negotiations fail. President Donald Trump signs ...
Organizations must guide AI use, not restrict it. Outright bans historically fail, pushing tech usage into riskier territory. Enterprises have seen this with shadow IT, where restrictive policies ...
[BRUSSELS] Brussels could hit US Big Tech with taxes if negotiations fail to end Donald Trump’s tariff war against the EU, the bloc’s chief Ursula von der Leyen said in a Financial Times interview ...
Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...
To address this question, a new study from Northwestern Medicine used modern technology, called CRISPR interference, to systematically examine every gene in the human genome. The scientists ...
To address this question, a new study from Northwestern Medicine used modern technology, called CRISPR interference, to systematically examine every gene in the human genome. The scientists ...
To address this question, a new study from Northwestern Medicine used modern technology, called CRISPR interference, to systematically examine every gene in the human genome. The scientists identified ...